Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor). by Cachero, T.G. et al.
Formation of Virus-like Clusters Is an Intrinsic Property of the Tumor Necrosis
Factor Family Member BAFF (B Cell Activating Factor)†
Teresa G. Cachero,*,‡ Ian M. Schwartz,‡,§ Fang Qian,‡ Eric S. Day,‡ Claudia Bossen,| Karine Ingold,|
Aubry Tardivel,| Dennis Krushinskie,‡ John Eldredge,‡ Laura Silvian,‡ Alexey Lugovskoy,‡ Graham K. Farrington,‡
Kathy Strauch,‡ Pascal Schneider,| and Adrian Whitty‡
Biogen Idec, Inc., 14 Cambridge Center, Cambridge, Massachusetts 02142, and Department of Biochemistry, UniVersity of
Lausanne, CH-1066 Epalinges, Switzerland
ReceiVed August 24, 2005; ReVised Manuscript ReceiVed December 6, 2005
ABSTRACT: The oligomeric state of BAFF (B cell activing factor), a tumor necrosis factor (TNF) family
cytokine that plays a critical role in B cell development and survival, has been the subject of recent
debate. Myc-tagged BAFF starting at residue Gln136 was previously reported to crystallize as trimers at
pH 4.5, whereas a histidine-tagged construct of BAFF, starting at residue Ala134, formed a virus-like
cluster containing 60 monomers when crystallized at pH 9.0. The formation of the BAFF 60-mer was pH
dependent, requiring pH g 7.0. More recently, 60-mer formation was suggested to be artificially induced
by the histidine tag, and it was proposed that BAFF, like all other TNF family members, is trimeric. We
report here that a construct of BAFF with no amino-terminal tag (Ala134-BAFF) can form a 60-mer in
solution. Using size exclusion chromatography and static light scattering to monitor trimer to 60-mer
ratios in BAFF preparations, we find that 60-mer formation is pH-dependent and requires histidine 218
within the DE loop of BAFF. Biacore measurements established that the affinity of Ala134-BAFF for the
BAFF receptor BAFFR/BR3 is similar to that of myc-Gln136-BAFF, which is exclusively trimeric in
solution. However, Ala134-BAFF is more efficacious than myc-Gln136-BAFF in inducing B cell
proliferation in vitro. We additionally show that BAFF that is processed and secreted by 293T cells
transfected with full-length BAFF, or by a histiocytic lymphoma cell line (U937) that expresses BAFF
endogenously, forms a pH-dependent 60-mer in solution. Our results indicate that the formation of the
60-mer in solution by the BAFF extracellular domain is an intrinsic property of the protein, and therefore
that this more active form of BAFF may be physiologically relevant.
BAFF1 (B cell activating factor), also known as BLyS,
TALL-1, THANK, and zTNF4, is a protein belonging to the
tumor necrosis factor (TNF) family of cytokines that is
critical for the survival of B cells. It is expressed in
macrophages, monocytes, dendritic cells, neutrophils, to a
lesser extent, T cells, and other nonhematopoetic cells
(reviewed in ref 1). BAFF is a type II transmembrane protein
that can be proteolytically cleaved between Arg133 and
Ala134 and released as a soluble protein (2, 3). BAFF
knockout mice lack mature B cells in the periphery, showing
that BAFF is required for B cell development in vivo (4, 5).
Mice overexpressing BAFF display symptoms of autoim-
mune disorders (6). Moreover, elevated levels of soluble
BAFF are detected in the blood of patients with various
autoimmune diseases (7-10). Interestingly, BAFF has also
been reported to form biologically active heteromers with
APRIL (a proliferation-inducing ligand), a closely related
TNF family ligand. These heterotrimers have been detected
in serum samples from patients with systemic immune-based
rheumatic diseases (11).
BAFF can signal through three receptors: B cell matura-
tion antigen (BCMA), transmembrane activator and cyclo-
philin ligand interactor (TACI), and BAFF receptor (BAFFR,
BR3). BCMA and TACI also bind APRIL (reviewed in ref
1). BAFF costimulates the proliferation of B cells in the
presence of anti-IgM antibody (3), and fusion proteins of
the BAFF receptors with the CH1, CH2, and hinge region of
human IgG1 were shown to block this activity in vitro (4,
7, 12, 13). BAFFR is expressed on all peripheral B cells
beyond the transitional type I stage of development and is
the specific receptor for BAFF (13, 14). Mice lacking
BAFFR have a phenotype similar to that of BAFF knockout
mice (13, 14). Recently, studies with monomeric receptors
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have shown that BAFF binds BAFFR with 100-fold higher
affinity than it binds BCMA (15).
All other TNF family ligands exist as trimers. We have
previously reported the crystal structure of the BAFF
extracellular domain, using a construct starting at residue
Gln136 and with an amino-terminal myc tag (myc-Q136-
BAFF). The structure, obtained at pH 4.5, showed two BAFF
trimers per asymmetric unit. Like other TNF family mem-
bers, each monomer of BAFF folds as a sandwich of two
antiparallel â-sheets. The structure of BAFF revealed that
the loop connecting â strands D and E is longer than the
corresponding loops seen in other TNF family members (16).
Oren and co-workers have independently reported the crystal
structure of BAFF at pH 6.0, which also showed a dimer of
trimers in the asymmetric unit (17). Interestingly, Liu et al.
(18) reported that a BAFF construct starting at residue
Ala134 and with an N-terminal histidine tag (His-A134-
BAFF), when crystallized at pH 9.0, displayed an oligomeric,
virus-like structure containing 20 trimers (60 monomers, 60-
mer). It appeared that the interaction between trimers was
mediated by the long DE loop. The authors showed that
formation of the BAFF 60-mer in solution was pH-depend-
ent, and was abolished by deletion of the DE loop. They
proposed that the ionization state of histidine 218 in the DE
loop is responsible for the pH dependence of 60-mer
formation (18). The crystal structures of the BAFF-BAFFR
and BAFF-BCMA complexes have been solved and show
a similar, virus-like BAFF 60-mer, with each of the 60
receptor binding sites occupied by a receptor molecule (19).
Recently, a report by Zhukovsky and colleagues questioned
the relevance of oligomeric BAFF in solution (20). They
suggested that BAFF, like other TNF family members, exists
as a trimer and that the 60-mer formation reported by Liu et
al. (18) was an artifact of the histidine tag present in their
construct. Furthermore, Zhukovsky and co-workers reported
that histidine-tagged and untagged BAFF protein showed
equivalent activity in a cell-based assay, from which they
concluded that 60-mer formation did not alter the functional
activity of the protein.
To characterize the ability of BAFF to form 60-mers in
solution and the consequences for functional activity, we
engineered a construct of BAFF comprising the TNF
homologous domain (Ala134-Leu285) with no amino-
terminal tag (A134-BAFF). Since A134-BAFF purified from
Pichia is glycosylated, we also engineered an aglycosylated
version, A134-BAFF-N242Q. We report here that both
A134-BAFF and A134-BAFF-N242Q form 60-mers in
solution in a pH-dependent manner and that 60-mer forma-
tion is abolished by the mutation of histidine 218 within the
DE loop to alanine. We also show that the affinity of A134-
BAFF for BAFFR is identical to that of myc-Q136-BAFF,
which we showed to be exclusively trimeric in solution, but
that A134-BAFF shows higher activity than myc-Q136-
BAFF in a cell-based assay measuring costimulation of B
cell proliferation. Taken together, our results indicate that
BAFF 60-mer formation does not require an N-terminal
histidine tag, but rather is an intrinsic property of the BAFF
protein. We additionally show that significant levels of the
BAFF 60-mer are detected in culture supernatants when
BAFF is naturally processed and secreted after transient
transfection into 293T cells, and also when BAFF is
endogenously expressed in U937 cells. These results support
the notion that the BAFF 60-mer is not just an in vitro
experimental artifact, but that this more active form of the
protein could have a physiological role.
MATERIALS AND METHODS
Expression of BAFF Proteins. All protein expression
was in Pichia pastoris GS115 using the methanol-inducible
native AOX1 promoter, or the GS115 derivative MMC216
using the doxycycline-inducible TetO-AOX1 promoter
(M. Levesque, D. Krushinskie, and K. Strauch, manuscript
in preparation). Expression plasmids used the R factor
secretion signal and the HIS4 selectable marker. Transforma-
tion was by electroporation or the P. pastoris EasyComp kit
(Invitrogen). Manipulation and strain construction methods
were as recommended by Invitrogen. StuI digestion was used
to linearize DNA prior to transformation. The N242Q and
H218A mutations were constructed by QuikChange (Strat-
agene) site-directed mutagenesis. Proteins were expressed
by shake flask induction in BMGY and BMMY (2% MeOH)
according to Invitrogen recommendations for Myc-BAFF,
or by fermentation in a reduced salts basal salts hexameta-
phosphate medium (M. Levesque, D. Krushinskie, and K.
Strauch, manuscript in preparation) for A134-BAFF (A134-
L285), A134-BAFF-H218A, His-A134-BAFF, and A134-
BAFF-N242Q. Induction in fermenters was achieved with
1 íg/mL doxycyline or by MeOH fed-batch growth.
Purification of BAFF Proteins. The following proteins
were expressed in P. pastoris: myc-Q136-BAFF (Q136-
L285), A134-BAFF (A134-L285), A134-BAFF-H218A,
A134-BAFF-N242Q, and His-A134-BAFF. The purification
of myc-BAFF was as reported (15). Briefly, P. pastoris
supernatants were diafiltered by tangential flow filtration
(Millipore, Pellicon II) and purified using ion exchange
chromatography (Q XL Sepharose, Q HP Sepharose, and
SP Sepharose; Amersham Biosciences). Purified proteins
were dialyzed against 10 mM Tris, pH 7.5, 150 mM NaCl.
His-A134-BAFF was purified on a nickel column (Amer-
sham Biosciences). Proteins were over 90% pure as con-
firmed by SDS-PAGE, and mass spectrometry analyses
confirmed that the proteins had the expected molecular mass.
Analytical Gel Filtration of Purified BAFF. BAFF proteins
were dialyzed for 3 h or overnight against the following
buffers containing 150 mM NaCl: pH 5.0 (25 mM sodium
acetate), pH 7.5 (10 mM Tris-HCl), pH 8.0 (20 mM Tris-
HCl), and pH 9.0 (20 mM Tris-HCl). Proteins (0.5-1 mg)
were then analyzed in a Superdex 200 10/30 tricorn column
(Amersham Biosciences) in the appropriate buffer. In some
cases, peak fractions were subsequently analyzed by Western
blotting using a rabbit polyclonal antibody raised against the
carboxy terminus of BAFF (Chemicon). In some instances,
peak fractions were concentrated 5-fold using Microcon YM-
30 (Amicon, Millipore, 30 000 MWCO) prior to Western
blot.
Gel Filtration Assays with Light Scattering. Size exclusion
chromatography (SEC) was carried out on a YMC-Pack Diol-
120 column, 8.0  300 mm (YMC, Inc., Wilmington, NC),
in 20 mM sodium phosphate buffer, pH 7.2, 150 mM NaCl
(PBS) using a flow rate of 0.6 mL/min on a Waters Alliance
instrument (Waters, Milford, MA). In addition to UV
detection, the eluent was monitored in tandem with a
refractive index detector (Waters) and a Precision Detector
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PD2000 light scattering instrument (Precision Detectors,
Bellingham, MA). Static light scattering was measured on a
Precision Detector PD2000/DLS instrument equipped with
a dual-angle flow cell detector. Molecular weight determi-
nation of each complex was performed with the Precision
Detector software.
Western Blots. The rabbit anti-human BAFF polyclonal
antibody was purchased from Upstate.
The ARH-77 plasma cell leukemia, Hut-78 cutaneous T
lymphoma, K562 chronic myelogenous leukemia, U266
myeloma, RPMI8226 myeloma, Molt-4 T acute lympho-
blastic leukemia, SKW6.4 B lymphoblast, U937 histiocytic
lymphoma, L428 Hodgkin’s lymphoma, THP-1 acute mono-
cytic leukemia, L363 plasma cell leukemia, BL41 Burkitt’s
lymphoma, OPM-2 myeloma, L428 Hodgkin’s lymphoma,
and HL-60 promyelocytic leukemia cell lines were obtained
from various collaborators and from the ATCC.
Immunoprecipitations. A 500 íL sample of cell superna-
tants was mixed with 1 íg/mL hBCMA-Fc (Axxora, San
Diego) and immunoprecipitated with 5 íL of Protein
A-Sepharose. Beads were recovered in microcolumns, washed
with 3  200 íL of PBS, and eluted with 15 íL of 0.1 M
citrate-NaOH, pH 2.7. The eluate was neutralized with 1
M Tris-HCl, pH 9, and analyzed by Western blotting.
Analytical Gel Filtration of BAFF in Cell Supernatants.
293T cells were transfected with a mammalian expression
vector for full-length, untagged hBAFF (3) and grown for 3
days in serum-free OptiMEM-1 medium (Invitrogen) supple-
mented with 10 mM Hepes, pH 7.4. U937 cells were grown
for 11 days in RPMI medium supplemented with 10% fetal
bovine serum and 0.1% sodium bicarbonate. Conditioned
supernatants were concentrated 10-fold in an Amicon Ultra
centrifugal filtration device with a molecular weight cutoff
of 10 000, and loaded (200 íL) onto a Superdex 200 10/30
column equilibrated in either PBS, pH 7.4, or 25 mM sodium
acetate, 150 mM NaCl, pH 5. The column was eluted at 0.5
mL/min, and fractions of 1.5 mL were collected. In the case
of U937 supernatants, 430 íL of the fractions was supple-
mented with 20 íg of bovine serum albumin and precipitated
for 10 min on ice with trichloroacetic acid at a final
concentration of 5%. After centrifugation, the supernatants
were carefully discarded, and the pellets were resuspended
by sonication in 60 íL of reducing SDS-PAGE sample
buffer. BAFF was detected by Western blotting with a rabbit
anti-BAFF polyclonal antibody (Upstate) and ECL reagent
(Amersham) or, for the Superdex elution of U937 superna-
tants, with SuperWest femto ECL reagent (Pierce).
Solution-Phase Affinity Measurements. All experiments
were performed on a Biacore 3000 instrument (Biacore AB,
Uppsala, Sweden). Chip preparation and solution-phase
binding measurements have been described (15). Briefly,
monomeric BAFFR and the various forms of BAFF were
mixed in different ratios in Biacore assay buffer (10 mM
HEPES, pH 7.0, 150 mM NaCl, 3.4 mM EDTA, 0.005%
P-20 detergent, 0.1% BSA) and preincubated for a minimum
of 3 h at 4 °C to reach equilibrium. The equilibrated solutions
were then injected over a BCMA-Fc-derivatized surface, and
the concentration of free BAFF in solution was measured.
The affinity of the interaction of BAFFR with various forms
of BAFF was determined from a plot of the concentration
of free BAFF versus total soluble receptor by fitting the data
to a quadratic binding equation as described (15).
B Cell Proliferation Assay. The proliferation assay has
been described (13, 15). Briefly, B cells isolated from mouse
splenocytes were incubated with 2 íg/mL goat anti-mouse
IgM antibody and different concentrations of BAFF for 48
h. Cells were pulsed for an additional 18 h with [3H]-
thymidine (Amersham Biosciences) (1 íCi/well) and har-
vested. [3H]Thymidine incorporation was monitored by liquid
scintillation counting.
RESULTS
To test whether the formation of the BAFF 60-mer is
dependent on the presence of an N-terminal histidine tag as
has been proposed (20), we engineered a BAFF construct
starting at amino acid alanine 134 with no amino-terminal
tag. This construct is similar to that reported by Liu and co-
workers (18), but lacking the histidine tag (Figure 1).
Recombinant BAFF purified from P. pastoris is glycosylated
at amino acid asparagine 242 (16). It has been shown that
soluble human BAFF expressed in 293T cells is not
glycosylated (3). Moreover, the construct reported by Liu
and co-workers was purified from Escherichia coli, and
hence was not glycosylated. Therefore, we also prepared a
second construct in which residue 242 was mutated to
glutamine (N242Q) to eliminate the N-linked glycosylation
site and thus ensure that our yeast-expressed protein was not
glycosylated. We refer to this protein as A134-BAFF-N242Q.
We evaluated the oligomeric state of both A134-BAFF
and A134-BAFF-N242Q in solution by analytical gel filtra-
tion at pH 7.5. When 5.8 íM Ala134-BAFF protein (molarity
based on the BAFF monomer) was loaded onto a gel
filtration column, the protein eluted as an oligomer (MW >
670 000) with a small portion eluting as a trimer (Figure 2).
To test how the formation of the 60-mer varies with protein
concentration, we analyzed the elution profile of A134-BAFF
at decreasing concentrations, and detected BAFF in peak
fractions by Western blot analysis. A134-BAFF eluted as a
60-mer at all tested concentrations, the lowest being 14 nM
FIGURE 1: Crystal structure of BAFF. The extracellular domain of
human BAFF (PDB ID 1kd7; 16) is shown in ribbon representation.
The three chains are colored in cyan, green, and pink. The DE loops
are colored in red. Side chains of amino acids N242 and H218 are
shown in stick representation.
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BAFF polypeptide corresponding to 245 pM 60-mer BAFF
(Figure 2 and data not shown). Similar results were observed
with Ala134-BAFF-N242Q, and with Ala134-BAFF that had
been preincubated in cell culture media (RPMI, 10% FBS)
for 24 or 48 h at 37 °C (data not shown) to mimic the
conditions used in subsequent cell-based assays. To directly
measure the molecular weight of the BAFF oligomers in
solution, we performed analytical gel filtration with in-line
light scattering (GF-LS) at pH 7.2 (21). Table 1 shows that
both A134-BAFF-N242Q and A134-BAFF eluted with a
molecular weight calculated from light scattering of 1 060 000
( 50 000. This value closely matches the molecular weight
expected for the BAFF 60-mer (1 022 000). We also prepared
a BAFF construct containing an N-terminal histidine tag
(His-A134-BAFF). In agreement with previous reports on
histidine-tagged BAFF (18, 20), this protein was also seen
to exist as a 60-mer by GF-LS (Table 1). The observation
that both A134-BAFF and His-A134-BAFF are able to form
oligomers in solution shows that BAFF 60-mer formation
does not require an N-terminal histidine tag. In contrast, two
constructs containing an N-terminal myc tag (myc-Q136-
BAFF-N242Q and myc-Q136) were shown to be exclusively
trimeric by analytical gel filtration and GF-LS with mo-
lecular weights from light scattering of 54 600 ( 3000 and
55 800 ( 3000 (Table 1).
To investigate the pH dependence of BAFF 60-mer
formation, we dialyzed A134-BAFF-N242Q in a series of
buffers with pH values ranging from 5.0 to 8.0. The
oligomeric state of BAFF was then determined by analytical
gel filtration as shown in Figure 3A. At pH 8.0 very little
trimeric BAFF was detected; the protein eluted largely as
an oligomer with an apparent molecular weight greater than
FIGURE 2: A134-BAFF forms a 60-mer in solution. Size exclusion
chromatography and Western blot analysis of A134-BAFF. SEC
was carried out as described in the Materials and Methods.
Molecular weight standards (A280, gray line) are as follows: A,
thyroglobulin, MW ) 670 000; B, ç globulin, MW ) 158 000; C,
ovalbumin, MW ) 44 000; D, myoglobulin, MW ) 17 000. A134-
BAFF was loaded onto the gel filtration column at the indicated
concentrations, eluted at 0.5 mL/min, and collected in 500 íL
fractions (A214, colored lines). A134-BAFF concentrations (mo-
larity based on the BAFF monomer) (nM) are 5850 (pink line),
1176 (green line), 294 (blue line), 147 (orange line), 73 (purple
line), and 14 (red line). The inset plot shows the Western blot of
the peak fractions. Molecular weight markers are shown between
the panels. The 60-mer panel corresponds to the peak eluting at
20 min, and the trimer panel corresponds to the peak eluting at
31 min.
Table 1: Measurement of the Molecular Weight of BAFF Proteins








A134-BAFF (60-mer) 1 060 000 1 022 000
A134-BAFF-N242Q (60-mer) 960 000 1 023 000
His-A134-BAFF (60-mer) 1 020 000 1 090 000
Q136-BAFF (60-mer) 1 070 000 1 012 000
Myc-Q136-BAFF (trimer) 55 800 55 600
Myc-Q136-BAFF-N24 2Q (trimer) 54 600 55 700
A134-BAFF-H218A (trimer) 56 600 50 900
FIGURE 3: Characterization of BAFF proteins by analytical gel
filtration. (A) pH dependence of 60-mer formation. A134-BAFF-
N242Q was analyzed at pH 5.0 (green) and pH 8.0 (blue). Buffer
conditions are described in the Materials and Methods. (B) H218A
mutation abolishes 60-mer formation. A134-BAFF-N242Q (blue)
and A134-BAFF-H218A (green) were analyzed in 10 mM Tris,
pH 7.5, 150 mM NaCl. (C) Myc-Q136-BAFF is trimeric even at
high pH. Myc-Q136-BAFF was characterized at pH 7.5 (blue) and
9.0 (green). The molecular weight markers shown are as in Figure
2 (gray).
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670 000. However, at pH 5.0, BAFF eluted as a trimer
(Figure 3A). This result indicates that a form of purified
BAFF that has no histidine tag at the amino terminus forms
a 60-mer in solution in a pH-dependent manner and thus
the pH dependence observed by Liu et al. (18) is not due to
ionization of the histidine tag.
To study the role of histidine 218 in 60-mer formation,
we engineered a construct in which histidine 218 was
mutated to alanine, A134-BAFF-H218A. The purified protein
was characterized by analytical gel filtration at pH 7.5 (Figure
3B) and also at pH 5.0 and 9.0 (data not shown). We found
that, unlike A134-BAFF, A134-BAFF-H218A was trimeric
in solution at all pH values tested (Figure 3B), suggesting
that the mutation H218A abolished oligomer formation. This
result extends the observation of Liu and co-workers (18),
who noted that deletion of the entire DE loop disrupts 60-
mer formation, by showing that the same result can be
achieved by this single-point mutation.
We also tested whether myc-Q136-BAFF, which is
exclusively trimeric at pH 7.5, can be induced to form a 60-
mer at high pH. To this end, we dialyzed the protein at pH
7.5 and 9.0 and analyzed its elution profile by analytical gel
filtration. As shown in Figure 3C, myc-Q136-BAFF does
not form a 60-mer even at high pH.
We next wanted to investigate whether naturally processed
full-length BAFF, and proteins produced by cell lines that
express BAFF endogenously, form a 60-mer. Transfected
293T cells have been shown to process full-length BAFF to
its soluble form (3). 293T cells transfected with full-length
human BAFF were grown in buffered culture medium to
minimize acidification of the supernatants. The supernatant
was shown by Western blot to contain secreted BAFF (data
not shown), and the oligomeric state of this protein was
analyzed by gel filtration. A significant fraction of the
secreted BAFF eluted as an oligomer (MW g 670 000),
consistent with the presence of a BAFF 60-mer (Figure 4A).
Identification of this fraction as a BAFF 60-mer was further
supported by the pH dependence of this high molecular
weight form of BAFF. In acidic conditions, the large
oligomer dissociated entirely into trimers, as expected for
the BAFF 60-mer (Figure 4A). To determine whether protein
secreted from cells that express BAFF endogenously also
exists as a 60-mer, we screened a number of cell lines for
the presence of soluble BAFF in their supernatants. A
reactive band of about 17 000 molecular weight, which is
the expected size for soluble BAFF, was readily detected in
conditioned supernatants of U937 histiocytic lymphoma cells
(Figure 4B). These cells have been described previously to
express BAFF (22), and we confirmed the identity of the
reactive protein by immunoprecipitation with BCMA-Fc
(Figure 4C). U937 cells were grown in buffered culture
medium to minimize acidification of the supernatants.
Analysis of the supernatants by gel filtration again showed
that a significant fraction of endogenous BAFF eluted as a
high molecular weight oligomer that was sensitive to acid
conditions (Figure 4D). Taken together, these results show
that a naturally cleaved, soluble form of BAFF with a high
molecular weight is detected in supernatants of cells that
express full-length BAFF ectopically and cells that express
BAFF endogenously. The size of this BAFF species and its
dissociation properties in acidic conditions strongly suggest
that naturally produced and processed BAFF can form 60-
mers.
In the presence of anti-IgM antibody, BAFF costimulates
the proliferation of B cells in vitro (3). Figure 5A shows
that oligomeric A134-BAFF is more efficacious than trimeric
myc-Q136-BAFF in inducing B cell proliferation in vitro.
Interestingly, the mutation H218A, which abolished 60-mer
formation, resulted in activity that was identical to that of
myc-Q136-BAFF (Figure 5A). Thus, myc-Q136-BAFF and
A134-BAFF-H218A represent forms of BAFF that are
unable to form a 60-mer but retain biological activity.
To test whether the difference in functional activity
observed between 60-mer and trimeric BAFF is due to a
FIGURE 4: Endogenous BAFF forms pH-dependent 60-mers. (A)
The 10 concentrated conditioned supernatants of 293T cells
transfected with full-length human BAFF were analyzed on a
Superdex-200 column equilibrated at pH 7.4 or 5. Samples of 20
íL out of 1.5 mL fractions were analyzed by Western blotting with
a rabbit anti-BAFF antibody. The elution position of molecular
weight markers is indicated at the top of the figure. (B) Samples
of 20 íL of conditioned supernatants from the indicated cell lines
were analyzed by Western blotting using a polyclonal rabbit anti-
BAFF antibody. Bands indicated as “ns” result from nonspecific
staining of unrelated proteins. (C) Cell supernatants of the indicated
cell lines were mixed with BCMA-Fc, immunoprecipitated with
Protein A-Sepharose, and analyzed by Western blotting using anti-
Ig and anti-BAFF antibodies. (D) The 10 concentrated conditioned
supernatants of U937 cells were analyzed on a Superdex-200
column as described above. Fractions were precipitated with 5%
trichloroacetic acid, and an equivalent of 50 or 180 íL of each
fraction was analyzed by Western blotting using the anti-BAFF
antibody. It was not possible to analyze 180 íL of fractions 10,
11, and 12 because of the high quantity of bovine serum albumin
contained in these fractions.
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difference in affinity for BAFFR, we evaluated the affinity
of BAFF trimer and 60-mer binding to soluble monomeric
BAFFR in solution using Biacore (Figure 5B). Titration of
soluble BAFFR against either 50 nM BAFF trimer or 2.5
nM BAFF 60-mer, equivalent to 150 nM BAFF polypeptide
in each case, shows that BAFFR binds to both forms of
BAFF with similar affinities (15 and 9 nM, respectively).
The affinity observed is in good agreement with previous
results (15).
DISCUSSION
The solution structure of BAFF at physiological pH is a
subject of debate. While some investigators believe that the
physiological form of BAFF is a trimer like other TNF family
ligands (20), others have reported that the active form of
BAFF is a virus-like 60-mer containing 20 homotrimers (18).
Formation of the BAFF 60-mer has been demonstrated by
crystallography and in solution using a construct containing
an amino-terminal histidine tag (18). In their cocrystallization
of BAFF with BAFFR, Kim et al. used untagged A134-
BAFF which was coexpressed in insect cells with dimeric
BAFFR-Fc (23). In this crystal structure BAFF appears as a
60-mer. However, they did not establish that this untagged
BAFF can form a 60-mer in solution or in the absence of
BAFFR-Fc. Zhukovsky et al. (20) observed that, of the three
constructs His-A134-BAFF, Flag-A134-BAFF, and untagged
A134-BAFF, only His-A134-BAFF formed 60-mers in
solution. They concluded that the ability of BAFF to form
60-mers is an artifact resulting from the presence of the
histidine tag.
In contrast to the results of Zhukovsky et al. (20), we found
by analytical gel filtration and light scattering that purified
untagged glycosylated A134-BAFF or aglycosylated A134-
BAFF-N242Q proteins form 60-mers in solution. It is not
clear why our results differ from those of Zhukovsky and
co-workers. We used a different expression system, P.
pastoris versus E. coli, and different buffer conditions, pH
7.5, no MgCl2 versus pH 8.0, 25 mM MgCl2. To rule out
buffer differences as a factor, we analyzed our untagged
A134-BAFF-N242Q by analytical gel filtration using the
same buffer conditions as Zhukovsky et al. and found that
the protein still eluted as a 60-mer (data not shown).
The pH dependence of 60-mer formation by His-A134-
BAFF was ascribed, by Zhukovsky et al. (20), to the
ionization state of the histidine tag, while Hong et al. (24)
suggested that the pH dependence was instead due to the
ionization of histidine 218 in the DE loop. The fact that our
untagged BAFF shows the same pH dependence for 60-mer
formation as that reported for the His-tagged protein indicates
that the histidine tag is not solely responsible for this effect.
Furthermore, our finding that mutating histidine 218 to
alanine abolished 60-mer formation even at pH 8.0-9.0
(Figure 3B, data not shown) is consistent with the pH
dependence being due to ionization of histidine 218.
BAFF is the only TNF family member that has an
extended DE loop (16, 18). This region is involved in
trimer-trimer interactions and was reported to be essential
for BAFF activity though not for receptor binding (18). The
importance of the DE loop region in the formation of the
60-mer is underlined by the finding that murine APRIL,
which lacks this long DE loop, is a trimeric protein at pH
values ranging from 5 to 8.5 (25). Our observation that the
H218A point mutation abolished 60-mer formation is
consistent with the role of the DE loop in 60-mer formation
(18) and confirms that H218 in particular is important in
mediating the interaction (24). However, in contrast to the
findings of Liu et al., our less drastic mutational change
allows us to separate the role of the DE loop in 60-mer
formation from its role in the activity of BAFF. Our His218A
construct, which gives rise exclusively to trimeric BAFF,
was active in the B cell proliferation assay. Therefore, if the
DE loop is required for functional activity, it is not solely
due to its role in mediating 60-mer formation.
Our results indicate that an active form of BAFF, myc-
Q136-BAFF, is not able to form 60-mers in solution even
at high pH. To examine why myc-Q136-BAFF cannot form
FIGURE 5: Functional activity of 60-mer versus trimeric BAFF.
(A) Proliferation of purified splenic B cells induced by trimeric
myc-Q136-BAFF (closed circles), trimeric A134-BAFF-H218A
(closed squares), 60-mer A134-BAFF (open circles), and 60-mer
A134-BAFF-N242Q (open squares). B cells were incubated in
quadruplicate in the presence of goat anti-mouse IgM antibody and
costimulated with increasing concentrations of BAFF. The data are
representative of three independent experiments. (B) Affinity of
myc-Q136-BAFF and A134-BAFF for monomeric BAFFR. The
indicated concentrations of soluble, monomeric BAFFR were
equilibrated in solution with a fixed concentration of BAFF (50
nM trimeric BAFF [myc-Q136, closed circles] or 2.5 nM 60-mer
BAFF [A134-BAFF, open circles]). Solutions were then run over
a BCMA-Fc-derivatized surface as described in the Materials and
Methods. The affinity of the solution-phase binding of BAFFR with
BAFF was determined by fitting the data to a quadratic binding
equation as described (15).
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60-mers, we attempted to pack additional N-terminal amino
acids of this construct inside the virus-like 60-mer structure
reported previously (18) using protein structure modeling
techniques (26, 27). The calculation (data not shown)
suggested that the N-terminal extension of myc-Q136-BAFF
is incompatible with virus-like assembly due to steric
crowding, in contrast to the smaller His tag extension,
providing a structural rationale for myc-Q136-BAFF being
a trimer in solution. The fact that the N-terminal histidine-
tagged BAFF forms a 60-mer suggests that the energetic
stabilization derived from trimer-trimer interaction mediated
by the DE loop overcomes any electrostatic repulsion arising
from the proximity of multiple histidine tags in the core of
the 60-mer.
For applications where an exclusively trimeric BAFF
protein is desired, myc-Q136-BAFF could be the construct
of choice. Previous works that used this construct (12, 13,
15, 16) presumably reflect the properties of the BAFF trimer
and are not influenced by the possibility of 60-mer formation.
The A134-BAFF-H218A provides an alternative construct
that it is solely trimeric and yet retains functional activity.
Having exclusively trimeric BAFF constructs in hand, we
were able to compare the activities of the trimer versus the
60-mer in receptor binding and functional assays. We find
that the BAFF trimer and 60-mer bind monomeric BAFFR
with similar affinities. This result is entirely consistent with
the cocrystal structure of BAFF and BAFFR in that the
crystal showed that the receptor binding sites on the BAFF
60-mer were fully accessible. There is, therefore, no structural
reason to expect that the monovalent affinity of the receptor
for the ligand would change between the trimer and 60-mer.
The structural and binding data also argue against the
existence of any significant allosteric cooperativity between
the different receptor binding sites in the BAFF 60-mer.
Most TNF family ligands are type II membrane proteins,
but many can be cleaved by metalloproteinases or furin-like
convertases and released as soluble molecules. This is the
case for TNF, Fas ligand (FasL), and BAFF, among others.
Reports have shown that soluble FasL is less cytotoxic than
membrane-bound FasL and that oligomerization of FasL is
required to trigger activity (28, 29). Unlike trimeric soluble
FasL, trimeric BAFF has been shown previously to be active
and able to costimulate B cell proliferation in vitro (Figure
5A) (12, 13). We reasoned that oligomeric BAFF could be
more active in inducing B cell proliferation than trimeric
BAFF due to the ability of 60-mer BAFF to engage more
receptors at the plasma membrane, which in turn might
induce a stronger signal. Our results indicate that the BAFF
60-mer is more active than the BAFF trimer in a B cell
proliferation assay in vitro. Control experiments showed that
the 60-mer remained intact when the protein was incubated
in cell culture media (RPMI) at concentrations comparable
to those used in this cell-based assay. The fact that the
activity difference seen with the BAFF 60-mer is manifested
in the amplitude of the response rather than its concentration
dependence suggests that the increased multivalency of the
60-mer affects the quality of the signal transduced rather than
just the avidity of binding. Although 60-mer formation has
not been demonstrated for murine BAFF, sequence alignment
shows that the DE loop is conserved between the human
and murine proteins. Mouse models may therefore be useful
to test the physiological relevance of BAFF 60-mers.
In conclusion, the ability of BAFF to form 60-mers in
solution at physiological pH is an intrinsic property of this
protein, and results in enhanced functional activity in vitro.
Furthermore, our analysis of BAFF secreted by 293T cells
transfected with full-length protein, and particularly by U937
cells that naturally express BAFF, shows that when expressed
endogenously and processed naturally BAFF indeed forms
60-mers. These findings show that BAFF 60-mer formation
is not restricted to truncated protein expressed ectopically,
and therefore support the idea that the more active, 60-mer
form of BAFF might occur in vivo and thus might have a
physiological role.
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